Seipin is required for converting nascent to mature lipid droplets

  1. Huajin Wang
  2. Michel Becuwe
  3. Benjamin E Housden
  4. Chandramohan Chitraju
  5. Ashley J Porras
  6. Morven M Graham
  7. Xinran N Liu
  8. Abdou Rachid Thiam
  9. David B Savage
  10. Anil K Agarwal
  11. Abhimanyu Garg
  12. Maria-Jesus Olarte
  13. Qingqing Lin
  14. Florian Fröhlich
  15. Hans Kristian Hannibal-Bach
  16. Srigokul Upadhyayula
  17. Norbert Perrimon
  18. Tomas Kirchhausen
  19. Christer S Ejsing
  20. Tobias C Walther  Is a corresponding author
  21. Robert V Farese  Is a corresponding author
  1. Carnegie Mellon University, United States
  2. Harvard T. H. Chan School of Public Health, United States
  3. Harvard Medical School, United States
  4. Yale School of Medicine, United States
  5. PSL Research University, France
  6. The University of Cambridge Metabolic Research Laboratories, United Kingdom
  7. UT Southwestern Medical Center, United States
  8. University of Southern Denmark, Denmark

Abstract

How proteins control the biogenesis of cellular lipid droplets (LDs) is poorly understood. Using Drosophila and human cells, we show here that seipin, an ER protein implicated in LD biology, mediates a discrete step in LD formation-the conversion of small, nascent LDs to larger, mature LDs. Seipin forms discrete and dynamic foci in the ER that interact with nascent LDs to enable their growth. In the absence of seipin, numerous small, nascent LDs accumulate near the ER and most often fail to grow. Those that do grow prematurely acquire lipid synthesis enzymes and undergo expansion, eventually leading to the giant LDs characteristic of seipin deficiency. Our studies identify a discrete step of LD formation, namely the conversion of nascent LDs to mature LDs, and define a molecular role for seipin in this process, most likely by acting at ER-LD contact sites to enable lipid transfer to nascent LDs.

Article and author information

Author details

  1. Huajin Wang

    Department of Biological Sciences, Carnegie Mellon University, Pittsburgh, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Michel Becuwe

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Benjamin E Housden

    Department of Genetics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Chandramohan Chitraju

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  5. Ashley J Porras

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  6. Morven M Graham

    Department of Cell Biology, Yale School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Xinran N Liu

    Department of Cell Biology, Yale School of Medicine, New Haven, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Abdou Rachid Thiam

    Laboratoire de Physique Statistique, École Normale Supérieure, PSL Research University, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. David B Savage

    Wellcome Trust-MRC Institute of Metabolic Science, The University of Cambridge Metabolic Research Laboratories, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Anil K Agarwal

    Division of Nutrition and Metabolic Diseases, UT Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  11. Abhimanyu Garg

    Division of Nutrition and Metabolic Diseases, UT Southwestern Medical Center, Dallas, United States
    Competing interests
    The authors declare that no competing interests exist.
  12. Maria-Jesus Olarte

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  13. Qingqing Lin

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Florian Fröhlich

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  15. Hans Kristian Hannibal-Bach

    Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  16. Srigokul Upadhyayula

    Departments of Cell Biology and Pediatrics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  17. Norbert Perrimon

    Department of Genetics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  18. Tomas Kirchhausen

    Departments of Cell Biology and Pediatrics, Harvard Medical School, Boston, United States
    Competing interests
    The authors declare that no competing interests exist.
  19. Christer S Ejsing

    Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  20. Tobias C Walther

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    For correspondence
    twalther@hsph.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
  21. Robert V Farese

    Department of Genetics and Complex Diseases, Harvard T. H. Chan School of Public Health, Boston, United States
    For correspondence
    robert@hsph.harvard.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8103-2239

Funding

National Institutes of Health (GM099844, GM097194, GM-075252)

  • Tomas Kirchhausen
  • Tobias C Walther
  • Robert V Farese

Howard Hughes Medical Institute

  • Norbert Perrimon
  • Tobias C Walther

G Harold and Leila Y. Mathers Foundation

  • Tobias C Walther

Villum Fonden (VKR023439)

  • Christer S Ejsing

Danish Council for Strategic Research (11-116196)

  • Christer S Ejsing

Wellcome Trust (WT107064)

  • David B Savage

Cambridge NIHR BRC

  • David B Savage

Biogen

  • Tomas Kirchhausen

Canadian Institutes of Health Research (Fellowship Award)

  • Huajin Wang

European Molecular Biology Organization (Longterm Fellowship EMBOLFT355)

  • Michel Becuwe

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2016, Wang et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,634
    views
  • 2,129
    downloads
  • 315
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Huajin Wang
  2. Michel Becuwe
  3. Benjamin E Housden
  4. Chandramohan Chitraju
  5. Ashley J Porras
  6. Morven M Graham
  7. Xinran N Liu
  8. Abdou Rachid Thiam
  9. David B Savage
  10. Anil K Agarwal
  11. Abhimanyu Garg
  12. Maria-Jesus Olarte
  13. Qingqing Lin
  14. Florian Fröhlich
  15. Hans Kristian Hannibal-Bach
  16. Srigokul Upadhyayula
  17. Norbert Perrimon
  18. Tomas Kirchhausen
  19. Christer S Ejsing
  20. Tobias C Walther
  21. Robert V Farese
(2016)
Seipin is required for converting nascent to mature lipid droplets
eLife 5:e16582.
https://doi.org/10.7554/eLife.16582

Share this article

https://doi.org/10.7554/eLife.16582

Further reading

    1. Cell Biology
    Zewei Zhao, Longyun Hu ... Zhonghan Yang
    Research Article

    The induction of adipose thermogenesis plays a critical role in maintaining body temperature and improving metabolic homeostasis to combat obesity. β3-adrenoceptor (β3-AR) is widely recognized as a canonical β-adrenergic G-protein-coupled receptor (GPCR) that plays a crucial role in mediating adipose thermogenesis in mice. Nonetheless, the limited expression of β3-AR in human adipocytes restricts its clinical application. The objective of this study was to identify a GPCR that is highly expressed in human adipocytes and to explore its potential involvement in adipose thermogenesis. Our research findings have demonstrated that the adhesion G-protein-coupled receptor A3 (ADGRA3), an orphan GPCR, plays a significant role in adipose thermogenesis through its constitutively active effects. ADGRA3 exhibited high expression levels in human adipocytes and mouse brown fat. Furthermore, the knockdown of Adgra3 resulted in an exacerbated obese phenotype and a reduction in the expression of thermogenic markers in mice. Conversely, Adgra3 overexpression activated the adipose thermogenic program and improved metabolic homeostasis in mice without exogenous ligand. We found that ADGRA3 facilitates the biogenesis of beige human or mouse adipocytes in vitro. Moreover, hesperetin was identified as a potential agonist of ADGRA3, capable of inducing adipocyte browning and ameliorating insulin resistance in mice. In conclusion, our study demonstrated that the overexpression of constitutively active ADGRA3 or the activation of ADGRA3 by hesperetin can induce adipocyte browning by Gs-PKA-CREB axis. These findings indicate that the utilization of hesperetin and the selective overexpression of ADGRA3 in adipose tissue could serve as promising therapeutic strategies in the fight against obesity.

    1. Cell Biology
    2. Chromosomes and Gene Expression
    Bethany M Bartlett, Yatendra Kumar ... Wendy A Bickmore
    Research Article Updated

    During oncogene-induced senescence there are striking changes in the organisation of heterochromatin in the nucleus. This is accompanied by activation of a pro-inflammatory gene expression programme – the senescence-associated secretory phenotype (SASP) – driven by transcription factors such as NF-κB. The relationship between heterochromatin re-organisation and the SASP has been unclear. Here, we show that TPR, a protein of the nuclear pore complex basket required for heterochromatin re-organisation during senescence, is also required for the very early activation of NF-κB signalling during the stress-response phase of oncogene-induced senescence. This is prior to activation of the SASP and occurs without affecting NF-κB nuclear import. We show that TPR is required for the activation of innate immune signalling at these early stages of senescence and we link this to the formation of heterochromatin-enriched cytoplasmic chromatin fragments thought to bleb off from the nuclear periphery. We show that HMGA1 is also required for cytoplasmic chromatin fragment formation. Together these data suggest that re-organisation of heterochromatin is involved in altered structural integrity of the nuclear periphery during senescence, and that this can lead to activation of cytoplasmic nucleic acid sensing, NF-κB signalling, and activation of the SASP.